PlainRecalls
FDA Devices Low Class III Terminated

DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

Reported: December 28, 2016 Initiated: November 16, 2016 #Z-0779-2017

Product Description

DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

Reason for Recall

A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76  67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.

Details

Units Affected
79 kits
Distribution
CA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,
Location
Waltham, MA

Frequently Asked Questions

What product was recalled?
DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum. Recalled by PerkinElmer Health Sciences, Inc.. Units affected: 79 kits.
Why was this product recalled?
A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76  67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 28, 2016. Severity: Low. Recall number: Z-0779-2017.